Dermaliq Therapeutics
Dr. Roesky is CEO & Managing Director of Novaliq since November 2016. Previously, Dr. Roesky was General Manager for the D-A-CH region of Bausch + Lomb GmbH in Berlin; Commercial Director Central Europe of Abbott’s Diagnostics Division, General Manager and speaker of the German Country Management Board of Abbott GmbH & Co. KG in Wiesbaden from 2013 – 2015; and, General Manager of Alcon Germany & Austria (Novartis) from 2009-2013. He studied chemistry in Bonn and Freiberg, both in Germany, and was awarded his Ph.D. with honors from the Technical University of Freiberg in Germany.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Dermaliq Therapeutics
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients